Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010203 11b dhk PGF2a cPLA2i 1.0 BCD110605C28 0.084 pmol/ml medium
LMFA03010203 11b dhk PGF2a cPLA2i 1.0 BCD110605C30 0.12 pmol/ml medium
LMFA03010203 11b dhk PGF2a cPLA2i 1.0 BCD110605C29 0.137 pmol/ml medium
LMFA03010203 11b dhk PGF2a cPLA2i 20.0 BCD110605C64 0.066 pmol/ml medium
LMFA03010203 11b dhk PGF2a cPLA2i 20.0 BCD110605C66 0.058 pmol/ml medium
LMFA03010203 11b dhk PGF2a cPLA2i 20.0 BCD110605C65 0.095 pmol/ml medium
LMFA03010203 11b dhk PGF2a PLDi 1.0 BCD110605C16 0.152 pmol/ml medium
LMFA03010203 11b dhk PGF2a PLDi 1.0 BCD110605C17 0.104 pmol/ml medium
LMFA03010203 11b dhk PGF2a PLDi 1.0 BCD110605C18 0.071 pmol/ml medium
LMFA03010203 11b dhk PGF2a PLDi 20.0 BCD110605C54 0.09 pmol/ml medium
LMFA03010203 11b dhk PGF2a PLDi 20.0 BCD110605C52 0.088 pmol/ml medium
LMFA03010203 11b dhk PGF2a PLDi 20.0 BCD110605C53 0.087 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+cPLA2i 1.0 BCD110605C32 0.11 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+cPLA2i 1.0 BCD110605C31 0.101 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+cPLA2i 1.0 BCD110605C33 0.109 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+cPLA2i 20.0 BCD110605C68 0.112 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+cPLA2i 20.0 BCD110605C69 0.088 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+cPLA2i 20.0 BCD110605C67 0.099 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+PLDi 1.0 BCD110605C19 0.12 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+PLDi 1.0 BCD110605C20 0.107 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+PLDi 1.0 BCD110605C21 0.134 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+PLDi 20.0 BCD110605C56 0.062 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+PLDi 20.0 BCD110605C57 0.099 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+PLDi 20.0 BCD110605C55 0.049 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C37 0.097 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C38 0.155 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+cPLA2i 1.0 BCD110605C39 0.135 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C74 0.135 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C75 0.15 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+cPLA2i 20.0 BCD110605C73 0.179 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+PLDi 1.0 BCD110605C25 0.159 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+PLDi 1.0 BCD110605C27 0.126 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+PLDi 1.0 BCD110605C26 0.108 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+PLDi 20.0 BCD110605C61 0.163 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+PLDi 20.0 BCD110605C62 0.117 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO+ATP+PLDi 20.0 BCD110605C63 0.22 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO + ATP 1.0 BCD110605C15 0.198 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO + ATP 1.0 BCD110605C14 0.137 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO + ATP 1.0 BCD110605C13 0.184 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO + ATP 20.0 BCD110605C49 0.157 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO + ATP 20.0 BCD110605C50 0.151 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO + ATP 20.0 BCD110605C51 0.108 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO 1.0 BCD110605C08 0.203 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO 1.0 BCD110605C07 0.21 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO 1.0 BCD110605C09 0.152 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO 20.0 BCD110605C45 0.077 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO 20.0 BCD110605C44 0.092 pmol/ml medium
LMFA03010203 11b dhk PGF2a KDO 20.0 BCD110605C43 0.131 pmol/ml medium
LMFA03010203 11b dhk PGF2a C 0.0 BCD110605C03 0.185 pmol/ml medium
LMFA03010203 11b dhk PGF2a C 0.0 BCD110605C01 0.293 pmol/ml medium